The same brain cells linked to disorientation in Alzheimer's disease have been preserved—and even slightly increased—across ...

In two studies, semaglutide failed to slow decline in thousands of people with early stages of Alzheimer's disease.

Michael Brady, 74, who had bipolar disorder and Alzheimer's disease, was killed in summer 2023 by Antoinette Sheppard, 43, ...

Millions of people are living with Alzheimer's disease, a progressive, irreversible brain disorder that causes cognitive decline, confusion, memory loss, and many other symptoms. The Alzheimer's Assoc ...

When you’re helping an aging parent manage doctors’ appointments, medications, or even the activities of daily life, you don’t need any reminders about the struggles of Alzheimer’s disease. You’re ...

For most older adults, the idea of aging in place and staying at home for as long as possible is an attractive one. However, for seniors who've been diagnosed with Alzheimer's disease or another ...

“Choosing a meaningful gift for someone living with dementia requires thoughtful consideration,” said Stacie Kulp, executive director of the Alzheimer’s Association of Utah, in a written statement.

Presenter: Audrey Gabelle, MD, PhD, Professor of Neurology, Neurologist and Member of the Anavex Scientific Advisory Board and Doctor in Neurosciences at the Memory Resources Research Center, the Rare ...

This study reveals genetic and proteomic risk factors for delirium, offering insights into its etiology and potential ...

A new study from Case Western Reserve University found that people who receive care within one week of a traumatic brain ...

A study reveals that arginine, a supplement used for high blood pressure, can reduce Alzheimer's symptoms in mice by clearing harmful protein build-ups.

Novo Nordisk faces setbacks with semaglutide in Alzheimer's trials and declining growth. Read here for analyst outlook and why NVO stock is rated Hold now.